{"id": "article-17149_0", "title": "Acute Chest Syndrome -- Continuing Education Activity", "content": "Acute chest syndrome occurs due to vaso-occlusion within the pulmonary vasculature of patients with sickle cell disease. This results in deoxygenation of hemoglobin and sickling of erythrocytes, which can cause further vaso-occlusion, ischemia, and endothelial injury. Acute chest syndrome can progress quickly and is the most common cause of death in patients with sickle cell disease. This activity reviews the etiology, pathophysiology, evaluation, and management of acute chest syndrome and highlights the role of interprofessional team members in caring for patients with this condition.", "contents": "Acute Chest Syndrome -- Continuing Education Activity. Acute chest syndrome occurs due to vaso-occlusion within the pulmonary vasculature of patients with sickle cell disease. This results in deoxygenation of hemoglobin and sickling of erythrocytes, which can cause further vaso-occlusion, ischemia, and endothelial injury. Acute chest syndrome can progress quickly and is the most common cause of death in patients with sickle cell disease. This activity reviews the etiology, pathophysiology, evaluation, and management of acute chest syndrome and highlights the role of interprofessional team members in caring for patients with this condition."}
{"id": "article-17149_1", "title": "Acute Chest Syndrome -- Continuing Education Activity", "content": "Objectives: Screen patients with sickle cell disease for early signs and symptoms of acute chest syndrome. Implement appropriate treatment interventions for acute chest syndrome based on the severity of the condition. Apply pharmacological interventions, such as analgesics, bronchodilators, and antibiotics, as indicated. Collaborate with hematologists, pulmonologists, respiratory therapists, and other specialists to manage acute chest syndrome. Access free multiple choice questions on this topic.", "contents": "Acute Chest Syndrome -- Continuing Education Activity. Objectives: Screen patients with sickle cell disease for early signs and symptoms of acute chest syndrome. Implement appropriate treatment interventions for acute chest syndrome based on the severity of the condition. Apply pharmacological interventions, such as analgesics, bronchodilators, and antibiotics, as indicated. Collaborate with hematologists, pulmonologists, respiratory therapists, and other specialists to manage acute chest syndrome. Access free multiple choice questions on this topic."}
{"id": "article-17149_2", "title": "Acute Chest Syndrome -- Introduction", "content": "Acute chest syndrome is a dangerous complication of sickle cell disease characterized by a new radiodensity on chest imaging accompanied by\u00a0respiratory symptoms and possibly fever. [1] Acute chest syndrome occurs when various factors in individuals with\u00a0sickle cell disease\u00a0trigger vaso-occlusion within the pulmonary vasculature. [2] While acute chest syndrome can occur in any sickle cell disease phenotype, it is most prevalent\u00a0in HbSS. [3] This syndrome can progress quickly and represents the leading cause of death in patients with sickle cell disease. [4] Therefore, early diagnosis and prompt initiation of\u00a0treatment are crucial to improve patient outcomes.", "contents": "Acute Chest Syndrome -- Introduction. Acute chest syndrome is a dangerous complication of sickle cell disease characterized by a new radiodensity on chest imaging accompanied by\u00a0respiratory symptoms and possibly fever. [1] Acute chest syndrome occurs when various factors in individuals with\u00a0sickle cell disease\u00a0trigger vaso-occlusion within the pulmonary vasculature. [2] While acute chest syndrome can occur in any sickle cell disease phenotype, it is most prevalent\u00a0in HbSS. [3] This syndrome can progress quickly and represents the leading cause of death in patients with sickle cell disease. [4] Therefore, early diagnosis and prompt initiation of\u00a0treatment are crucial to improve patient outcomes."}
{"id": "article-17149_3", "title": "Acute Chest Syndrome -- Etiology", "content": "Acute chest syndrome can be attributed to various\u00a0inciting factors. While the distinct etiology of most cases remains unclear, fat or bone marrow emboli are suspected of causing most adult patients. [5] Postmortem\u00a0analysis of bronchoalveolar lavage in individuals\u00a0who succumbed to\u00a0sickle cell disease often\u00a0reveals the presence of alveolar macrophages containing fat. Vaso-occlusive crises, characterized by bone marrow ischemia and necrosis, can release bone marrow and fat into the venous circulation. These particles can subsequently\u00a0travel to the lungs, triggering vaso-occlusion and ultimately causing acute chest syndrome.", "contents": "Acute Chest Syndrome -- Etiology. Acute chest syndrome can be attributed to various\u00a0inciting factors. While the distinct etiology of most cases remains unclear, fat or bone marrow emboli are suspected of causing most adult patients. [5] Postmortem\u00a0analysis of bronchoalveolar lavage in individuals\u00a0who succumbed to\u00a0sickle cell disease often\u00a0reveals the presence of alveolar macrophages containing fat. Vaso-occlusive crises, characterized by bone marrow ischemia and necrosis, can release bone marrow and fat into the venous circulation. These particles can subsequently\u00a0travel to the lungs, triggering vaso-occlusion and ultimately causing acute chest syndrome."}
{"id": "article-17149_4", "title": "Acute Chest Syndrome -- Etiology", "content": "Other causes of acute chest syndrome include infection, asthma, hypoxemia, oversedation, and postoperative complications. Infection is often a common inciting event in children. Asthma-related bronchospasm can lead to hypoxia, which leads to sickling. Patients with sickle cell disease and asthma are 2 to 4 times more prone\u00a0to developing\u00a0acute chest syndrome than those with\u00a0sickle cell disease alone. [6]", "contents": "Acute Chest Syndrome -- Etiology. Other causes of acute chest syndrome include infection, asthma, hypoxemia, oversedation, and postoperative complications. Infection is often a common inciting event in children. Asthma-related bronchospasm can lead to hypoxia, which leads to sickling. Patients with sickle cell disease and asthma are 2 to 4 times more prone\u00a0to developing\u00a0acute chest syndrome than those with\u00a0sickle cell disease alone. [6]"}
{"id": "article-17149_5", "title": "Acute Chest Syndrome -- Etiology", "content": "Chronic hypoxemia is commonly observed\u00a0in individuals\u00a0with concurrent\u00a0sickle cell disease and asthma, particularly\u00a0in children overnight. Notably, these patients may exhibit normal oxygen saturation during the day but develop hypoxia at night, which can contribute\u00a0to sickling. Postoperative patients may experience hypoventilation due to pain or sedating medications, which can provoke sickling in the pulmonary circulation and result in acute chest syndrome.", "contents": "Acute Chest Syndrome -- Etiology. Chronic hypoxemia is commonly observed\u00a0in individuals\u00a0with concurrent\u00a0sickle cell disease and asthma, particularly\u00a0in children overnight. Notably, these patients may exhibit normal oxygen saturation during the day but develop hypoxia at night, which can contribute\u00a0to sickling. Postoperative patients may experience hypoventilation due to pain or sedating medications, which can provoke sickling in the pulmonary circulation and result in acute chest syndrome."}
{"id": "article-17149_6", "title": "Acute Chest Syndrome -- Etiology", "content": "It is worth mentioning that patients with sickle cell disease are more inclined\u00a0to develop in situ thrombi in the pulmonary circulation rather than a pulmonary embolism. [5] Nevertheless, the possibility of pulmonary embolism should still be considered if the patient has signs of deep venous thrombosis in the extremities or clinical manifestations\u00a0suggestive of pulmonary embolism.", "contents": "Acute Chest Syndrome -- Etiology. It is worth mentioning that patients with sickle cell disease are more inclined\u00a0to develop in situ thrombi in the pulmonary circulation rather than a pulmonary embolism. [5] Nevertheless, the possibility of pulmonary embolism should still be considered if the patient has signs of deep venous thrombosis in the extremities or clinical manifestations\u00a0suggestive of pulmonary embolism."}
{"id": "article-17149_7", "title": "Acute Chest Syndrome -- Epidemiology", "content": "Acute chest syndrome\u00a0is the most prevalent\u00a0acute pulmonary disorder in individuals\u00a0with sickle cell disease. [5] Approximately 50%\u00a0of patients with sickle cell disease will experience\u00a0more than 1\u00a0episode of acute chest syndrome. The peak incidence of acute chest syndrome is observed in pediatric patients between 2 and\u00a04 years old. Among adults, 78% of acute chest syndrome episodes are secondary to vaso-occlusive pain episodes. Acute chest syndrome is the most common cause of death in\u00a0individuals with sickle cell disease, accounting for nearly 25% of all deaths. The mortality rates associated with acute chest syndrome are 4.3% in adults and 1.1% in children.", "contents": "Acute Chest Syndrome -- Epidemiology. Acute chest syndrome\u00a0is the most prevalent\u00a0acute pulmonary disorder in individuals\u00a0with sickle cell disease. [5] Approximately 50%\u00a0of patients with sickle cell disease will experience\u00a0more than 1\u00a0episode of acute chest syndrome. The peak incidence of acute chest syndrome is observed in pediatric patients between 2 and\u00a04 years old. Among adults, 78% of acute chest syndrome episodes are secondary to vaso-occlusive pain episodes. Acute chest syndrome is the most common cause of death in\u00a0individuals with sickle cell disease, accounting for nearly 25% of all deaths. The mortality rates associated with acute chest syndrome are 4.3% in adults and 1.1% in children."}
{"id": "article-17149_8", "title": "Acute Chest Syndrome -- Pathophysiology", "content": "Approximately 40% of acute chest syndrome cases in children can be attributed to a specific cause. Among those\u00a0cases with identifiable causes, about 40% are associated with infections. Viral infections, mycoplasma pneumonia, and\u00a0chlamydia pneumonia are the most frequently encountered infectious causes. [5] Pulmonary infarction and fat embolism are also significant contributors to acute chest syndrome in children.", "contents": "Acute Chest Syndrome -- Pathophysiology. Approximately 40% of acute chest syndrome cases in children can be attributed to a specific cause. Among those\u00a0cases with identifiable causes, about 40% are associated with infections. Viral infections, mycoplasma pneumonia, and\u00a0chlamydia pneumonia are the most frequently encountered infectious causes. [5] Pulmonary infarction and fat embolism are also significant contributors to acute chest syndrome in children."}
{"id": "article-17149_9", "title": "Acute Chest Syndrome -- Pathophysiology", "content": "In adult patients, approximately half of those\u00a0who develop acute chest syndrome are initially admitted for other reasons, frequently vaso-occlusive crises. As previously discussed, vaso-occlusive crises can lead to the release of bone marrow or fat emboli to the pulmonary circulation, which are the primary causes of acute chest syndrome. Vaso-occlusive crises of the spine, ribs, and abdomen carry additional risk. In these regions, vaso-occlusive crises can lead to hypoventilation due\u00a0to both pain and the use of opioids, subsequently\u00a0triggering hypoxemia and alveolar hypoxia. This, in turn, results in\u00a0low arterial oxygen tension and promotes\u00a0sickling, leading to the development of acute chest syndrome.", "contents": "Acute Chest Syndrome -- Pathophysiology. In adult patients, approximately half of those\u00a0who develop acute chest syndrome are initially admitted for other reasons, frequently vaso-occlusive crises. As previously discussed, vaso-occlusive crises can lead to the release of bone marrow or fat emboli to the pulmonary circulation, which are the primary causes of acute chest syndrome. Vaso-occlusive crises of the spine, ribs, and abdomen carry additional risk. In these regions, vaso-occlusive crises can lead to hypoventilation due\u00a0to both pain and the use of opioids, subsequently\u00a0triggering hypoxemia and alveolar hypoxia. This, in turn, results in\u00a0low arterial oxygen tension and promotes\u00a0sickling, leading to the development of acute chest syndrome."}
{"id": "article-17149_10", "title": "Acute Chest Syndrome -- Pathophysiology", "content": "The pathophysiology of acute chest syndrome is based on vaso-occlusion within the pulmonary microvasculature. Regardless of\u00a0the inciting event, the process starts with the deoxygenation of hemoglobin, leading to polymerization and sickling of erythrocytes. Sickled erythrocytes further contribute to vaso-occlusion, causing ischemia and injury to the endothelial cells.", "contents": "Acute Chest Syndrome -- Pathophysiology. The pathophysiology of acute chest syndrome is based on vaso-occlusion within the pulmonary microvasculature. Regardless of\u00a0the inciting event, the process starts with the deoxygenation of hemoglobin, leading to polymerization and sickling of erythrocytes. Sickled erythrocytes further contribute to vaso-occlusion, causing ischemia and injury to the endothelial cells."}
{"id": "article-17149_11", "title": "Acute Chest Syndrome -- Pathophysiology", "content": "Fat emboli can induce the\u00a0release of free fatty acids within the pulmonary vasculature through the action of phospholipase A2. These free fatty acids have pro-inflammatory properties, which can trigger pulmonary injury with resultant hypoxemia. [7]", "contents": "Acute Chest Syndrome -- Pathophysiology. Fat emboli can induce the\u00a0release of free fatty acids within the pulmonary vasculature through the action of phospholipase A2. These free fatty acids have pro-inflammatory properties, which can trigger pulmonary injury with resultant hypoxemia. [7]"}
{"id": "article-17149_12", "title": "Acute Chest Syndrome -- History and Physical", "content": "The presentation of acute chest syndrome differs\u00a0between pediatric and adult patients. In pediatric patients, who are more prone to infectious causes, symptoms such as wheezing, coughing, increased work of breathing, and fevers are commonly observed. [8] On the other hand, adult patients often\u00a0present with chest pain, pain in the extremities, dyspnea,\u00a0or may exhibit signs of vaso-occlusive crises in other parts\u00a0of the body (eg, priapism). [1]", "contents": "Acute Chest Syndrome -- History and Physical. The presentation of acute chest syndrome differs\u00a0between pediatric and adult patients. In pediatric patients, who are more prone to infectious causes, symptoms such as wheezing, coughing, increased work of breathing, and fevers are commonly observed. [8] On the other hand, adult patients often\u00a0present with chest pain, pain in the extremities, dyspnea,\u00a0or may exhibit signs of vaso-occlusive crises in other parts\u00a0of the body (eg, priapism). [1]"}
{"id": "article-17149_13", "title": "Acute Chest Syndrome -- Evaluation", "content": "Diagnosing acute chest syndrome depends on radiographic evidence and clinical symptoms. To\u00a0be diagnosed with acute chest syndrome, a patient must meet the following criteria: [8] [9] New pulmonary infiltrates on chest imaging (chest x-ray, CT) involving at least one lung segment; this cannot be due to atelectasis and must have one of the following symptoms: Chest pain Temperature more than 38.5 C Tachypnea, wheezing, rales, coughing, the appearance of an increased work of breathing Hypoxemia, relative to baseline (more than 2% decrease in SpO2 from steady state on room air, PaO2 less than 60 mmHg)", "contents": "Acute Chest Syndrome -- Evaluation. Diagnosing acute chest syndrome depends on radiographic evidence and clinical symptoms. To\u00a0be diagnosed with acute chest syndrome, a patient must meet the following criteria: [8] [9] New pulmonary infiltrates on chest imaging (chest x-ray, CT) involving at least one lung segment; this cannot be due to atelectasis and must have one of the following symptoms: Chest pain Temperature more than 38.5 C Tachypnea, wheezing, rales, coughing, the appearance of an increased work of breathing Hypoxemia, relative to baseline (more than 2% decrease in SpO2 from steady state on room air, PaO2 less than 60 mmHg)"}
{"id": "article-17149_14", "title": "Acute Chest Syndrome -- Evaluation", "content": "These criteria lack specificity and can also be diagnostic of pneumonia. Therefore, obtaining\u00a0a chest radiograph for every patient presenting with respiratory symptoms and sickle cell disease is crucial, as acute chest syndrome can have an insidious start. Early initiation of treatment is essential in managing this condition effectively.", "contents": "Acute Chest Syndrome -- Evaluation. These criteria lack specificity and can also be diagnostic of pneumonia. Therefore, obtaining\u00a0a chest radiograph for every patient presenting with respiratory symptoms and sickle cell disease is crucial, as acute chest syndrome can have an insidious start. Early initiation of treatment is essential in managing this condition effectively."}
{"id": "article-17149_15", "title": "Acute Chest Syndrome -- Evaluation -- Risk Factors", "content": "Low fetal hemoglobin (HbF) Young age Presence of asthma or other hyperreactive lung disorder Smoking Recent trauma or surgery", "contents": "Acute Chest Syndrome -- Evaluation -- Risk Factors. Low fetal hemoglobin (HbF) Young age Presence of asthma or other hyperreactive lung disorder Smoking Recent trauma or surgery"}
{"id": "article-17149_16", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Clinicians should maintain a high suspicion for acute chest syndrome during a vaso-occlusive crisis. Early recognition and prompt initiation of treatment are associated with\u00a0lower mortality rates, shorter hospital stays, decreased healthcare costs, and a reduced likelihood\u00a0of recurrence. [10] Once initiated, the treatment of acute chest syndrome should\u00a0be aggressive due to the potential rapid progression of the disease. [11] [12]", "contents": "Acute Chest Syndrome -- Treatment / Management. Clinicians should maintain a high suspicion for acute chest syndrome during a vaso-occlusive crisis. Early recognition and prompt initiation of treatment are associated with\u00a0lower mortality rates, shorter hospital stays, decreased healthcare costs, and a reduced likelihood\u00a0of recurrence. [10] Once initiated, the treatment of acute chest syndrome should\u00a0be aggressive due to the potential rapid progression of the disease. [11] [12]"}
{"id": "article-17149_17", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Acute chest syndrome management involves several key components, including\u00a0pain control, intravenous fluids, antibiotics, supplemental oxygen, and blood transfusions. Pain control in pediatric patients typically\u00a0begins with using ketorolac, as\u00a0it is a non-sedating medication and is less likely to cause hypoventilation than\u00a0opioid pain medications. The risk of hypoventilation and subsequent complications can be minimized by effectively managing pain.", "contents": "Acute Chest Syndrome -- Treatment / Management. Acute chest syndrome management involves several key components, including\u00a0pain control, intravenous fluids, antibiotics, supplemental oxygen, and blood transfusions. Pain control in pediatric patients typically\u00a0begins with using ketorolac, as\u00a0it is a non-sedating medication and is less likely to cause hypoventilation than\u00a0opioid pain medications. The risk of hypoventilation and subsequent complications can be minimized by effectively managing pain."}
{"id": "article-17149_18", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "In adult patients, pain management can also begin with the use of ketorolac. In adult and pediatric patients, if\u00a0ketorolac and acetaminophen do not provide sufficient pain relief, opioid pain medication may be required. These opioid medications are preferably administered through a patient-controlled analgesia (PCA) device. Achieving adequate pain control in acute chest syndrome is a delicate balance between ensuring proper analgesia to prevent atelectasis and avoiding oversedation, which can lead to hypoventilation and hypoxia.", "contents": "Acute Chest Syndrome -- Treatment / Management. In adult patients, pain management can also begin with the use of ketorolac. In adult and pediatric patients, if\u00a0ketorolac and acetaminophen do not provide sufficient pain relief, opioid pain medication may be required. These opioid medications are preferably administered through a patient-controlled analgesia (PCA) device. Achieving adequate pain control in acute chest syndrome is a delicate balance between ensuring proper analgesia to prevent atelectasis and avoiding oversedation, which can lead to hypoventilation and hypoxia."}
{"id": "article-17149_19", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Fluid management is necessary to manage acute chest syndrome, particularly in cases of dehydration, as hypovolemia can exacerbate\u00a0sickling. However, current recommendations\u00a0no longer support using\u00a0large-volume intravenous hydration, as excessive fluid administration can contribute to\u00a0pulmonary edema and further\u00a0respiratory complications. Instead, fluid management should be guided\u00a0by the patient's hydration status to restore and maintain adequate hydration without causing fluid overload.", "contents": "Acute Chest Syndrome -- Treatment / Management. Fluid management is necessary to manage acute chest syndrome, particularly in cases of dehydration, as hypovolemia can exacerbate\u00a0sickling. However, current recommendations\u00a0no longer support using\u00a0large-volume intravenous hydration, as excessive fluid administration can contribute to\u00a0pulmonary edema and further\u00a0respiratory complications. Instead, fluid management should be guided\u00a0by the patient's hydration status to restore and maintain adequate hydration without causing fluid overload."}
{"id": "article-17149_20", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Broad-spectrum antibiotics should be administered\u00a0to every patient with acute chest syndrome. The risk of infection is higher in the pediatric population, but it is still significant in adult patients. Distinguishing between acute chest syndrome and pneumonia can be challenging. While there is a lack\u00a0of randomized clinical trials assessing the\u00a0efficacy and\u00a0potential harm of antibiotics in acute chest syndrome, it is recommended to initiate antibiotics.", "contents": "Acute Chest Syndrome -- Treatment / Management. Broad-spectrum antibiotics should be administered\u00a0to every patient with acute chest syndrome. The risk of infection is higher in the pediatric population, but it is still significant in adult patients. Distinguishing between acute chest syndrome and pneumonia can be challenging. While there is a lack\u00a0of randomized clinical trials assessing the\u00a0efficacy and\u00a0potential harm of antibiotics in acute chest syndrome, it is recommended to initiate antibiotics."}
{"id": "article-17149_21", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "A third-generation cephalosporin such as cefotaxime or ceftriaxone is commonly prescribed for routine bacterial coverage. A\u00a0macrolide such as azithromycin or erythromycin is recommended for atypical coverage. Alternatively, a respiratory fluoroquinolone such as levofloxacin or moxifloxacin can be used as a monotherapy. [1] [13] If there is a concern for methicillin-resistant Staphylococcus aureus (MRSA) infection, vancomycin should be added to the antibiotic regimen. The duration of treatment is typically\u00a07 to 10 days.", "contents": "Acute Chest Syndrome -- Treatment / Management. A third-generation cephalosporin such as cefotaxime or ceftriaxone is commonly prescribed for routine bacterial coverage. A\u00a0macrolide such as azithromycin or erythromycin is recommended for atypical coverage. Alternatively, a respiratory fluoroquinolone such as levofloxacin or moxifloxacin can be used as a monotherapy. [1] [13] If there is a concern for methicillin-resistant Staphylococcus aureus (MRSA) infection, vancomycin should be added to the antibiotic regimen. The duration of treatment is typically\u00a07 to 10 days."}
{"id": "article-17149_22", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "To prevent atelectasis, incentive spirometry should be performed\u00a0every 2 hours while the patient is awake. This helps promote deep breathing and lung expansion, reducing the risk of complications associated with atelectasis.", "contents": "Acute Chest Syndrome -- Treatment / Management. To prevent atelectasis, incentive spirometry should be performed\u00a0every 2 hours while the patient is awake. This helps promote deep breathing and lung expansion, reducing the risk of complications associated with atelectasis."}
{"id": "article-17149_23", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Supplemental oxygen should be administered\u00a0to correct a low oxygen saturation (SpO 2 ) or arterial partial pressure of oxygen (PaO 2 ) in patients with acute chest syndrome. However, providing\u00a0supplemental oxygen to all\u00a0acute chest syndrome patients is reasonable, even if their oxygen saturation appears normal. This is recommended because a normal oxygen saturation can mask focal areas of hypoxemia. Some evidence suggests that early administration of supplemental oxygen may reduce the need for\u00a0blood transfusions and is well tolerated. [12]", "contents": "Acute Chest Syndrome -- Treatment / Management. Supplemental oxygen should be administered\u00a0to correct a low oxygen saturation (SpO 2 ) or arterial partial pressure of oxygen (PaO 2 ) in patients with acute chest syndrome. However, providing\u00a0supplemental oxygen to all\u00a0acute chest syndrome patients is reasonable, even if their oxygen saturation appears normal. This is recommended because a normal oxygen saturation can mask focal areas of hypoxemia. Some evidence suggests that early administration of supplemental oxygen may reduce the need for\u00a0blood transfusions and is well tolerated. [12]"}
{"id": "article-17149_24", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Co-oximetry is the most reliable\u00a0method\u00a0for monitoring oxygen levels in individuals with sickle cell disease due to their characteristic shift in the oxyhemoglobin dissociation curve to the right. This shift can lead to underestimating a patient's oxygen pressure when using pulse oximetry and overestimating arterial blood gas measurements.", "contents": "Acute Chest Syndrome -- Treatment / Management. Co-oximetry is the most reliable\u00a0method\u00a0for monitoring oxygen levels in individuals with sickle cell disease due to their characteristic shift in the oxyhemoglobin dissociation curve to the right. This shift can lead to underestimating a patient's oxygen pressure when using pulse oximetry and overestimating arterial blood gas measurements."}
{"id": "article-17149_25", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "In sickle cell disease, it is recommended to maintain the SpO 2 above 92% and PaO2 above 70 mm Hg or no less than 3% below the individual's baseline. If supplemental oxygen is insufficient to correct hypoxemia, treatment\u00a0should be escalated. In severe cases, this may involve interventions such as bi-level positive airway pressure (BiPAP) ventilation, intubation, or even extracorporeal membrane oxygenation (ECMO). [13] [14]", "contents": "Acute Chest Syndrome -- Treatment / Management. In sickle cell disease, it is recommended to maintain the SpO 2 above 92% and PaO2 above 70 mm Hg or no less than 3% below the individual's baseline. If supplemental oxygen is insufficient to correct hypoxemia, treatment\u00a0should be escalated. In severe cases, this may involve interventions such as bi-level positive airway pressure (BiPAP) ventilation, intubation, or even extracorporeal membrane oxygenation (ECMO). [13] [14]"}
{"id": "article-17149_26", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Packed red blood cell transfusions have demonstrated some\u00a0effectiveness in case series for managing acute chest syndrome. However,\u00a0there is a lack of\u00a0randomized controlled trials\u00a0evaluating the use of packed red blood cell transfusions versus supportive therapy for managing acute chest syndrome.", "contents": "Acute Chest Syndrome -- Treatment / Management. Packed red blood cell transfusions have demonstrated some\u00a0effectiveness in case series for managing acute chest syndrome. However,\u00a0there is a lack of\u00a0randomized controlled trials\u00a0evaluating the use of packed red blood cell transfusions versus supportive therapy for managing acute chest syndrome."}
{"id": "article-17149_27", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Transfusions are\u00a0administered\u00a0to improve oxygenation in acute chest syndrome and have been\u00a0observed to increase both SpO 2 and PaO 2 . Blood transfusions are indicated when the hemoglobin level is 10% to 20% below baseline, the hemoglobin is less than 7 g/dL,\u00a0 a\u00a0decreasing hematocrit trend is seen, worsening radiographic signs\u00a0or worsening symptoms are present, or a delay in performing an exchange transfusion occurs. [1]", "contents": "Acute Chest Syndrome -- Treatment / Management. Transfusions are\u00a0administered\u00a0to improve oxygenation in acute chest syndrome and have been\u00a0observed to increase both SpO 2 and PaO 2 . Blood transfusions are indicated when the hemoglobin level is 10% to 20% below baseline, the hemoglobin is less than 7 g/dL,\u00a0 a\u00a0decreasing hematocrit trend is seen, worsening radiographic signs\u00a0or worsening symptoms are present, or a delay in performing an exchange transfusion occurs. [1]"}
{"id": "article-17149_28", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Packed red blood cell transfusion aims to increase\u00a0the hematocrit to 30% or hemoglobin to 10 g/dL. In severe cases of acute chest syndrome, exchange transfusions\u00a0may be warranted. Indications\u00a0for exchange transfusions\u00a0include severe hypoxemia, the presence of multilobar disease on chest radiographs, or failure of improvement with blood transfusion. An exchange transfusion aims to increase hemoglobin to 10 g/dL and\u00a0reduce the percentage of sickle hemoglobin\u00a0(HbS) to less than 30%. Exchange transfusion allows for an increase in hemoglobin\u00a0while avoiding the risk of hyperviscosity. When considering the need for transfusion or exchange transfusion, it is advisable to consult a hematologist experienced in managing sickle cell disease and its complications.", "contents": "Acute Chest Syndrome -- Treatment / Management. Packed red blood cell transfusion aims to increase\u00a0the hematocrit to 30% or hemoglobin to 10 g/dL. In severe cases of acute chest syndrome, exchange transfusions\u00a0may be warranted. Indications\u00a0for exchange transfusions\u00a0include severe hypoxemia, the presence of multilobar disease on chest radiographs, or failure of improvement with blood transfusion. An exchange transfusion aims to increase hemoglobin to 10 g/dL and\u00a0reduce the percentage of sickle hemoglobin\u00a0(HbS) to less than 30%. Exchange transfusion allows for an increase in hemoglobin\u00a0while avoiding the risk of hyperviscosity. When considering the need for transfusion or exchange transfusion, it is advisable to consult a hematologist experienced in managing sickle cell disease and its complications."}
{"id": "article-17149_29", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Bronchodilators are indicated only in cases\u00a0with evidence of underlying asthma or a bronchospastic component contributing to the presentation. However, routine use of bronchodilators has not shown any measurable benefits in treating acute chest syndrome. [15]", "contents": "Acute Chest Syndrome -- Treatment / Management. Bronchodilators are indicated only in cases\u00a0with evidence of underlying asthma or a bronchospastic component contributing to the presentation. However, routine use of bronchodilators has not shown any measurable benefits in treating acute chest syndrome. [15]"}
{"id": "article-17149_30", "title": "Acute Chest Syndrome -- Treatment / Management", "content": "Steroids have\u00a0shown efficacy in reducing\u00a0the length of hospital stay in patients with acute chest syndrome. However, their use is associated with a higher rate of rebound vaso-occlusive crises, an increased risk of readmission, and an increased risk of fat emboli. Bronchoscopy with bronchoalveolar lavage (BAL) is indicated only in cases where acute chest syndrome is refractory to conventional treatment. [16]", "contents": "Acute Chest Syndrome -- Treatment / Management. Steroids have\u00a0shown efficacy in reducing\u00a0the length of hospital stay in patients with acute chest syndrome. However, their use is associated with a higher rate of rebound vaso-occlusive crises, an increased risk of readmission, and an increased risk of fat emboli. Bronchoscopy with bronchoalveolar lavage (BAL) is indicated only in cases where acute chest syndrome is refractory to conventional treatment. [16]"}
{"id": "article-17149_31", "title": "Acute Chest Syndrome -- Differential Diagnosis", "content": "When evaluating a patient with symptoms of acute chest syndrome, it is important to consider a broad range of potential causes. The following is a list of differential diagnoses with a description of their symptoms that should be considered: Acute coronary syndrome: conditions such as unstable angina and myocardial infarction, chest pain, shortness of breath, and other cardiac symptoms Pulmonary embolism: sudden-onset chest pain, shortness of breath, and potentially life-threatening symptoms. Pneumothorax: sudden-onset sharp chest pain and difficulty breathing Pneumonia: productive cough, fever, chest pain, and difficulty breathing Pleural effusion: chest pain, shortness of breath, and reduced breath sounds on examination Empyema: chest pain, fever, productive cough, and difficulty breathing Aortic dissection: severe chest pain radiating to the back Acute respiratory distress syndrome (ARDS): difficulty breathing, low oxygen levels, and chest X-ray abnormalities", "contents": "Acute Chest Syndrome -- Differential Diagnosis. When evaluating a patient with symptoms of acute chest syndrome, it is important to consider a broad range of potential causes. The following is a list of differential diagnoses with a description of their symptoms that should be considered: Acute coronary syndrome: conditions such as unstable angina and myocardial infarction, chest pain, shortness of breath, and other cardiac symptoms Pulmonary embolism: sudden-onset chest pain, shortness of breath, and potentially life-threatening symptoms. Pneumothorax: sudden-onset sharp chest pain and difficulty breathing Pneumonia: productive cough, fever, chest pain, and difficulty breathing Pleural effusion: chest pain, shortness of breath, and reduced breath sounds on examination Empyema: chest pain, fever, productive cough, and difficulty breathing Aortic dissection: severe chest pain radiating to the back Acute respiratory distress syndrome (ARDS): difficulty breathing, low oxygen levels, and chest X-ray abnormalities"}
{"id": "article-17149_32", "title": "Acute Chest Syndrome -- Prognosis", "content": "Acute chest syndrome is a common and potentially severe complication in individuals with sickle cell disease, with approximately 50% of patients experiencing an episode at some point. [1] Acute chest syndrome significantly contributes to mortality in sickle cell disease, accounting for\u00a0about 25% of deaths. In adults, the mortality rate\u00a0can be as high as 9% per episode of acute chest syndrome.", "contents": "Acute Chest Syndrome -- Prognosis. Acute chest syndrome is a common and potentially severe complication in individuals with sickle cell disease, with approximately 50% of patients experiencing an episode at some point. [1] Acute chest syndrome significantly contributes to mortality in sickle cell disease, accounting for\u00a0about 25% of deaths. In adults, the mortality rate\u00a0can be as high as 9% per episode of acute chest syndrome."}
{"id": "article-17149_33", "title": "Acute Chest Syndrome -- Prognosis", "content": "When\u00a0considering\u00a0the pediatric population, acute chest syndrome is more likely to recur in younger children, particularly those\u00a0younger than 4. [17] Several factors have been identified as predictors of repeat hospitalization in children, including a history of asthma, shortness of breath, and longer initial length of stays upon presentation and hospitalization with acute chest syndrome. Long-term complications of acute chest syndrome may include recurrent episodes of acute chest syndrome, interstitial lung disease, and pulmonary hypertension.", "contents": "Acute Chest Syndrome -- Prognosis. When\u00a0considering\u00a0the pediatric population, acute chest syndrome is more likely to recur in younger children, particularly those\u00a0younger than 4. [17] Several factors have been identified as predictors of repeat hospitalization in children, including a history of asthma, shortness of breath, and longer initial length of stays upon presentation and hospitalization with acute chest syndrome. Long-term complications of acute chest syndrome may include recurrent episodes of acute chest syndrome, interstitial lung disease, and pulmonary hypertension."}
{"id": "article-17149_34", "title": "Acute Chest Syndrome -- Complications", "content": "Acute chest syndrome can lead to various complications, including those listed below. ARDS can result from severe lung inflammation and fluid accumulation. This condition impairs oxygenation and can lead to respiratory failure. Respiratory failure occurs due to significant impairment in lung function, characterized by inadequate oxygenation and ventilation. Pulmonary infarction occurs when a blood clot lodges in a pulmonary artery, leading to tissue damage and impaired lung function. Pulmonary fibrosis\u00a0can result from recurrent episodes of acute chest syndrome. Pulmonary fibrosis involves the scarring and thickening of lung tissue, leading to impaired lung function and long-term respiratory compromise. Pulmonary hypertension is due to chronic lung damage from acute chest syndrome. This condition can also lead to heart strain and impaired cardiac function. Severe pain Death", "contents": "Acute Chest Syndrome -- Complications. Acute chest syndrome can lead to various complications, including those listed below. ARDS can result from severe lung inflammation and fluid accumulation. This condition impairs oxygenation and can lead to respiratory failure. Respiratory failure occurs due to significant impairment in lung function, characterized by inadequate oxygenation and ventilation. Pulmonary infarction occurs when a blood clot lodges in a pulmonary artery, leading to tissue damage and impaired lung function. Pulmonary fibrosis\u00a0can result from recurrent episodes of acute chest syndrome. Pulmonary fibrosis involves the scarring and thickening of lung tissue, leading to impaired lung function and long-term respiratory compromise. Pulmonary hypertension is due to chronic lung damage from acute chest syndrome. This condition can also lead to heart strain and impaired cardiac function. Severe pain Death"}
{"id": "article-17149_35", "title": "Acute Chest Syndrome -- Deterrence and Patient Education", "content": "Long-term management\u00a0strategies for\u00a0acute chest syndrome include hydroxyurea, packed red blood cell transfusions, and hematopoietic cell transplants.", "contents": "Acute Chest Syndrome -- Deterrence and Patient Education. Long-term management\u00a0strategies for\u00a0acute chest syndrome include hydroxyurea, packed red blood cell transfusions, and hematopoietic cell transplants."}
{"id": "article-17149_36", "title": "Acute Chest Syndrome -- Deterrence and Patient Education", "content": "Hydroxyurea is a medication shown to decrease the frequency of acute chest syndrome by 50% in adults and 30% in children. [17] Hydroxyurea works by increasing the concentration of\u00a0HbF in red blood cells. It is\u00a0the only medication shown to decrease the incidence of acute chest syndrome.", "contents": "Acute Chest Syndrome -- Deterrence and Patient Education. Hydroxyurea is a medication shown to decrease the frequency of acute chest syndrome by 50% in adults and 30% in children. [17] Hydroxyurea works by increasing the concentration of\u00a0HbF in red blood cells. It is\u00a0the only medication shown to decrease the incidence of acute chest syndrome."}
{"id": "article-17149_37", "title": "Acute Chest Syndrome -- Deterrence and Patient Education", "content": "Chronic red blood cell transfusions can be utilized\u00a0during the transition to hydroxyurea in high-risk periods (such as winter) if hydroxyurea is ineffective or if the patient is recovering from a life-threatening episode of acute chest syndrome. It's important to note that chronic transfusions carry risks, including\u00a0the potential for infections, iron overload, and allosensitization.", "contents": "Acute Chest Syndrome -- Deterrence and Patient Education. Chronic red blood cell transfusions can be utilized\u00a0during the transition to hydroxyurea in high-risk periods (such as winter) if hydroxyurea is ineffective or if the patient is recovering from a life-threatening episode of acute chest syndrome. It's important to note that chronic transfusions carry risks, including\u00a0the potential for infections, iron overload, and allosensitization."}
{"id": "article-17149_38", "title": "Acute Chest Syndrome -- Deterrence and Patient Education", "content": "A hematopoietic cell transplant is an option for patients with sickle cell disease who have experienced multiple episodes of acute chest syndrome. This procedure requires an HLA-matched sibling donor and involves myeloablative regiments with associated risks. However, hematopoietic cell transplant has shown a success rate of over 80% in treating sickle cell disease.", "contents": "Acute Chest Syndrome -- Deterrence and Patient Education. A hematopoietic cell transplant is an option for patients with sickle cell disease who have experienced multiple episodes of acute chest syndrome. This procedure requires an HLA-matched sibling donor and involves myeloablative regiments with associated risks. However, hematopoietic cell transplant has shown a success rate of over 80% in treating sickle cell disease."}
{"id": "article-17149_39", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "Recent\u00a0research\u00a0in acute chest syndrome\u00a0has focused on enhancing diagnosis, understanding the disease characteristics, and improving treatment strategies. Two areas of interest in current research include bedside ultrasound for diagnosis and evaluating biomarkers for early detection.", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. Recent\u00a0research\u00a0in acute chest syndrome\u00a0has focused on enhancing diagnosis, understanding the disease characteristics, and improving treatment strategies. Two areas of interest in current research include bedside ultrasound for diagnosis and evaluating biomarkers for early detection."}
{"id": "article-17149_40", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "Bedside ultrasound has emerged as a promising method for detecting acute chest syndrome. It has shown potential for higher\u00a0sensitivity compared to traditional imaging methods like X-rays.\u00a0Ultrasound findings\u00a0such as\u00a0b-lines, pleural effusions, and consolidations\u00a0have demonstrated greater\u00a0sensitivity in predicting the progression to acute chest syndrome in individuals evaluated for a pain crisis. [8]", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. Bedside ultrasound has emerged as a promising method for detecting acute chest syndrome. It has shown potential for higher\u00a0sensitivity compared to traditional imaging methods like X-rays.\u00a0Ultrasound findings\u00a0such as\u00a0b-lines, pleural effusions, and consolidations\u00a0have demonstrated greater\u00a0sensitivity in predicting the progression to acute chest syndrome in individuals evaluated for a pain crisis. [8]"}
{"id": "article-17149_41", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "In addition to imaging techniques,\u00a0researchers are exploring using biomarkers\u00a0to aid in the early detection of acute chest syndrome. One biomarker under study is serum phospholipase A2, which converts neutral fats to free fatty acids. Studies have shown that levels of free fatty acids increase hours before the onset of acute chest syndrome. [18] This\u00a0indicates that measuring free fatty acid levels in the future could be a predictive tool for identifying individuals at risk of developing acute chest syndrome.", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. In addition to imaging techniques,\u00a0researchers are exploring using biomarkers\u00a0to aid in the early detection of acute chest syndrome. One biomarker under study is serum phospholipase A2, which converts neutral fats to free fatty acids. Studies have shown that levels of free fatty acids increase hours before the onset of acute chest syndrome. [18] This\u00a0indicates that measuring free fatty acid levels in the future could be a predictive tool for identifying individuals at risk of developing acute chest syndrome."}
{"id": "article-17149_42", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "The severity of acute chest syndrome\u00a0can vary among\u00a0individuals. Within the broader group of patients who develop this condition, a subset experiences a rapidly progressive course. [19] This subgroup\u00a0tends to have\u00a0poorer outcomes\u00a0than the larger group of patients with acute chest syndrome.\u00a0In particular,\u00a0low platelet counts in adults\u00a0have been\u00a0identified as a risk factor for a more rapid disease progression and generally worse outcomes.", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. The severity of acute chest syndrome\u00a0can vary among\u00a0individuals. Within the broader group of patients who develop this condition, a subset experiences a rapidly progressive course. [19] This subgroup\u00a0tends to have\u00a0poorer outcomes\u00a0than the larger group of patients with acute chest syndrome.\u00a0In particular,\u00a0low platelet counts in adults\u00a0have been\u00a0identified as a risk factor for a more rapid disease progression and generally worse outcomes."}
{"id": "article-17149_43", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "Evidence-based interventions for acute chest syndrome are limited.\u00a0In the case of\u00a0inhaled nitric oxide, a\u00a0randomized controlled trial\u00a0did not find a difference in outcomes for treating acute chest syndrome. [20] However, there was some evidence that a subgroup with more severe hypoxemia in the trial could have experienced a modest benefit. Inhaled nitric oxide is a pulmonary vasodilator, which should improve ventilation-perfusion mismatching and decrease pulmonary hypertension. It may also increase the oxygen affinity of hemoglobin S (HbS), leading to less sickling of erythrocytes.", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. Evidence-based interventions for acute chest syndrome are limited.\u00a0In the case of\u00a0inhaled nitric oxide, a\u00a0randomized controlled trial\u00a0did not find a difference in outcomes for treating acute chest syndrome. [20] However, there was some evidence that a subgroup with more severe hypoxemia in the trial could have experienced a modest benefit. Inhaled nitric oxide is a pulmonary vasodilator, which should improve ventilation-perfusion mismatching and decrease pulmonary hypertension. It may also increase the oxygen affinity of hemoglobin S (HbS), leading to less sickling of erythrocytes."}
{"id": "article-17149_44", "title": "Acute Chest Syndrome -- Pearls and Other Issues", "content": "Current practice\u00a0for managing acute chest syndrome often includes\u00a0regular packed red blood cell transfusions and consideration of exchange transfusion in severe cases. However, evidence suggests that the length of hospital stay is unchanged between groups with acute chest syndrome who\u00a0received an exchange transfusion and those who did not. [21] Decreased length of hospital stay was found in subgroups that targeted transfusion goals to hemoglobin >8.0 g/dL.", "contents": "Acute Chest Syndrome -- Pearls and Other Issues. Current practice\u00a0for managing acute chest syndrome often includes\u00a0regular packed red blood cell transfusions and consideration of exchange transfusion in severe cases. However, evidence suggests that the length of hospital stay is unchanged between groups with acute chest syndrome who\u00a0received an exchange transfusion and those who did not. [21] Decreased length of hospital stay was found in subgroups that targeted transfusion goals to hemoglobin >8.0 g/dL."}
{"id": "article-17149_45", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Acute chest syndrome is a serious complication of sickle cell anemia with high morbidity and mortality. Many individuals diagnosed with acute chest syndrome have repeated episodes of sickle cell pain crises or recurrence of acute chest syndrome. It is essential to attempt to minimize the risk of recurrence with education and a multidisciplinary coordinated care approach. Studies have shown that implementing a\u00a0coordinated\u00a0care team can decrease the incidence of acute chest syndrome, decrease the number of ICU admissions, and decrease the length of stay for vaso-occlusive crises. [22] A collaborative and multidisciplinary approach involving various healthcare professionals is crucial in managing acute chest syndrome. The following key points should be emphasized and organized:", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Acute chest syndrome is a serious complication of sickle cell anemia with high morbidity and mortality. Many individuals diagnosed with acute chest syndrome have repeated episodes of sickle cell pain crises or recurrence of acute chest syndrome. It is essential to attempt to minimize the risk of recurrence with education and a multidisciplinary coordinated care approach. Studies have shown that implementing a\u00a0coordinated\u00a0care team can decrease the incidence of acute chest syndrome, decrease the number of ICU admissions, and decrease the length of stay for vaso-occlusive crises. [22] A collaborative and multidisciplinary approach involving various healthcare professionals is crucial in managing acute chest syndrome. The following key points should be emphasized and organized:"}
{"id": "article-17149_46", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Incentive spirometer and respiratory therapy: The nursing and respiratory therapy teams should encourage patients admitted with acute chest syndrome to utilize the incentive spirometer. This helps prevent lung collapse and improves lung function.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Incentive spirometer and respiratory therapy: The nursing and respiratory therapy teams should encourage patients admitted with acute chest syndrome to utilize the incentive spirometer. This helps prevent lung collapse and improves lung function."}
{"id": "article-17149_47", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Patient-reported pain score: A patient-reported pain score is essential for assessing and treating pain crises and acute chest syndrome. It remains the gold standard for detecting pain in sickle cell disease. No other sign, symptom, or lab value is more accurate in detecting pain. In challenging cases, a pain consultant may be necessary to optimize pain control while avoiding over-sedation and hypoventilation.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Patient-reported pain score: A patient-reported pain score is essential for assessing and treating pain crises and acute chest syndrome. It remains the gold standard for detecting pain in sickle cell disease. No other sign, symptom, or lab value is more accurate in detecting pain. In challenging cases, a pain consultant may be necessary to optimize pain control while avoiding over-sedation and hypoventilation."}
{"id": "article-17149_48", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Consulting with specialists: Hematologist: Consultation with a hematologist is essential to assess the need for blood transfusions and plasma exchange to manage acute chest syndrome. Pulmonologist: If the patient has asthma, chronic obstructive pulmonary disease (COPD), or restrictive lung disease, consulting a pulmonologist is crucial as these conditions are associated with high morbidity in acute chest syndrome.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Consulting with specialists: Hematologist: Consultation with a hematologist is essential to assess the need for blood transfusions and plasma exchange to manage acute chest syndrome. Pulmonologist: If the patient has asthma, chronic obstructive pulmonary disease (COPD), or restrictive lung disease, consulting a pulmonologist is crucial as these conditions are associated with high morbidity in acute chest syndrome."}
{"id": "article-17149_49", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Importance of hydroxyurea: Even after a single episode of acute chest syndrome, patients and their families should be educated about the importance of hydroxyurea. Hydroxyurea is a potent inducer of\u00a0HbF and has been shown to lower the risk of sickle cell crises.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Importance of hydroxyurea: Even after a single episode of acute chest syndrome, patients and their families should be educated about the importance of hydroxyurea. Hydroxyurea is a potent inducer of\u00a0HbF and has been shown to lower the risk of sickle cell crises."}
{"id": "article-17149_50", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Vaccination against pneumococcus: Besides the physician, the nurse and pharmacist play a vital role in educating patients about the importance of pneumococcal vaccination. Studies have shown that implementing vaccination has led to a significant decline in the incidence of acute chest syndrome in specific populations. [23]", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Vaccination against pneumococcus: Besides the physician, the nurse and pharmacist play a vital role in educating patients about the importance of pneumococcal vaccination. Studies have shown that implementing vaccination has led to a significant decline in the incidence of acute chest syndrome in specific populations. [23]"}
{"id": "article-17149_51", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes", "content": "Extensive patient education and return precautions: Patients should receive comprehensive education about acute chest syndrome and its management. Strict return precautions should be emphasized to ensure early initiation of treatment, as prognosis improves with timely intervention.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes. Extensive patient education and return precautions: Patients should receive comprehensive education about acute chest syndrome and its management. Strict return precautions should be emphasized to ensure early initiation of treatment, as prognosis improves with timely intervention."}
{"id": "article-17149_52", "title": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes -- Outcomes", "content": "Acute chest syndrome is a severe complication of sickle cell anemia that necessitates hospital admission. No randomized clinical trials are available that\u00a0compare standardized treatments\u00a0for acute chest syndrome. While some\u00a0studies indicate a fair-to-good outcome in the short term when acute chest syndrome is treated early and aggressively, other evidence suggests high morbidity and mortality without aggressive treatment. [13] [24] Patients must be started on hydroxyurea to prevent future episodes. [Level 5] In severe and recurrent cases, hematopoietic cell transplant should be considered.", "contents": "Acute Chest Syndrome -- Enhancing Healthcare Team Outcomes -- Outcomes. Acute chest syndrome is a severe complication of sickle cell anemia that necessitates hospital admission. No randomized clinical trials are available that\u00a0compare standardized treatments\u00a0for acute chest syndrome. While some\u00a0studies indicate a fair-to-good outcome in the short term when acute chest syndrome is treated early and aggressively, other evidence suggests high morbidity and mortality without aggressive treatment. [13] [24] Patients must be started on hydroxyurea to prevent future episodes. [Level 5] In severe and recurrent cases, hematopoietic cell transplant should be considered."}
{"id": "article-17149_53", "title": "Acute Chest Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Acute Chest Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}